• Customer Care
  • (888) 123-4567

Translational Research Assistant

Rise Therapeutics is recruiting a full-time research assistant experienced with in vivo murine studies and in vitro molecular biology techniques in our Rockville, MD laboratory. The candidate will be responsible for performing a variety of in vitro testing and in vivo murine technical procedures to support Rise` programs. This position offers a unique opportunity to advance skills and experience necessary for a successful career in the biotechnology industry.

Duties and Responsibilities:

Support the design and execution of in vivo murine research studies.

Provide murine in vivo pharmacology and disease model expertise across multiple projects within our drug discovery portfolio.

Perform daily animal husbandry tasks.

Responsibilities include performing technical procedures such as animal identification, collecting biological samples, assisting scientists with requirements related to their research animals, and administering medicines/compounds.

Responsible for receiving animals and stocking facility supplies.

Perform analytical testing and analysis of biological specimens.

Perform in vitro studies, including cytokine and protein analyses, and microbiology testing.

Perform molecular biology techniques.

Responsible for documenting daily tasks and communicating progress appropriately to the manager.

Required Qualifications

Degree (BS, MS) in the life sciences or biomedical engineering.

Previous experience working in animal research using murine disease models.

Background in analytical assay work, cell culture, microbiology, and molecular biology.

Effective communication skills with the ability to contribute in a fast-paced environment.

Strong sense of responsibility for deadlines and data accuracy.

Rigor and attention to detail including laboratory notebook documentation.

Comfort with collaboration in a team-based environment.



Support initiatives to develop new treatments for autoimmunity, infection, and cancer

Gain experience working in an industry-leading biotech company

Mentorship from seasoned research entrepreneurs and business executives

Expand relationships/connections with leading biotechnology researchers


Please email your CV or resume to: This email address is being protected from spambots. You need JavaScript enabled to view it.


About Rise Therapeutics

Rise Therapeutics is an emerging, privately held company located in Rockville, Maryland which leverages its expertise in synthetic biology and immunological drug development to create novel cellular-based immune therapies. With a strong emphasis on product development and its internal clinical GMP manufacturing infrastructure, Rise is focused on developing immunological-based biological medicines using a unique and proprietary oral biologics delivery platform. Our drug development focus is driven by new microbiome-related discoveries enabling development of targeted, first-in-class immune modulatory drugs for the treatment of inflammation, autoimmunity, cancer, and infection. In the context of its expertise in synthetic biology medicine, proprietary TPX oral drug delivery platform, and clinical GMP manufacturing capabilities, Rise is creating and rapidly advancing life changing cellular-based medicines to the market. For more information, go to www.risetherapeutics.com.


Our News

Rockville, Maryland, October 19, 2023 – Rise Therapeutics, a biotechnology company engaged in developing novel oral immunotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application to proceed with a rheumatoid arthritis Phase 1 clinical trial for its program candidate, R-2487. This is Rise Therapeutics’ second clinical program developed using synthetic biology and its proprietary oral biologics delivery platform.

Biotech company receives follow-on funding to accelerate ongoing clinical development efforts

TEDCO, Maryland’s economic engine for technology companies, announced a recent Seed Funds investment of $200,000 into Rise Therapeutics, a Maryland-based biotechnology company. TEDCO’s Seed Funds invest in early-stage, technology and life sciences companies and provides access to gap financing.

Rockville, Maryland - Rise Therapeutics, a biotech company focused on developing novel immunological-directed synthetic biology-based therapeutics, announced today that it has received funding from the National Institutes of Health (NIH) to develop a novel therapeutic for Acute Respiratory Distress Syndrome (ARDS). The funding will support completion of product validation studies and preparation for clinical development for the program. Rise’s functionally directed immunotherapy engages natural gut microbiome-associated immunological processes with the potential to diminish lung neutrophilia, reduce inflammation, upregulate regulatory T cells, and restore airways epithelial barrier to balance and reset the patient’s immunological repertoire.